Cite
APA Citation
Hofman, M. S., Emmett, L., Violet, J., Y. Zhang, A., Lawrence, N. J., Stockler, M., Francis, R. J., Iravani, A., Williams, S., Azad, A., Martin, A., McJannett, M., , , & Davis, I. D. (n.d.). theraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU international, 124, 5–13. http://access.bl.uk/ark:/81055/vdc_100095338534.0x00001a